Previously, we showed that shRNA-mediated knockdown of capn2 in murine mammary carcinoma engraftment model [9] or knockdown of capns1 in a human triple negative breast cancer xenograft model [25] attenuated tumor growth at the orthotopic site. The gene discussed is CAPNS1; the disease is triple-negative breast carcinoma.